Over the past decade, Sweden's pharmaceutical imports have exhibited variability with an overall upward trend. From 2013 to 2023, the value increased from $4.52 billion to $6.79 billion. The period between 2015 and 2023 saw accelerated growth with an average annual growth rate (CAGR) of 8.04%. Year-on-year variations were notable, with significant increases in 2020 (11.85%) and continued growth into 2022 and 2023 at 6.91% and 6.58% respectively. In 2023, Sweden's pharmaceutical imports stood at $6.79 billion USD.
Looking ahead, the imports are forecasted to continue growing at a steady pace, with a five-year CAGR of 4.14% projected, rising to $8.83 billion by 2028, representing a forecasted growth rate of 22.48%. Key future trends to watch include advances in biotechnology, increased demand for innovative drugs, and regulatory changes that may impact import dynamics.
